The Week Ahead In Biotech (Nov. 21-Nov. 27)
Biotech stocks showed a lack of direction in the week ending Nov. 19 before finishing modestly higher. Stocks did not have much meaningful catalysts to react to amid the winding down of the reporting season and ahead of the holiday week.
Among the major news of the week was $Pfizer(PFE.US$ filing an application for emergency use authorization for its oral COVID-19 pill Paxlovid. The company also bagged a $5.29 billion contract from the U.S. government to supply the investigational antiviral treatment and announced a voluntary license agreement with a U.N.-backed body to facilitate greater access to the global population.
$Biogen(BIIB.US$ was also in the news due to long-time company veteran and R&D head Alfred Sandrock, who oversaw the development of many breakthrough neurological treatments, announcing his retirement.
$Connect Biopharma(CNTB.US$ came under intense selling pressure after what seemed like positive topline data from the Phase 2 study of its investigational therapy CBP-201 in atopic dermatitis. Lack of efficacy details from each arm of the study irked investors, as they could not weigh in vis-à-vis existing treatments.
On the other hand, $Longeveron(LGVN.US$ shares nearly doubled during the week after its Lomecel-B for hypoplastic left heart syndrome drug received a rare pediatric disease designation from the Food and Drug Administration.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Video Sharer
news porter, welcome and respect all view~
1910Followers
33Following
5168Visitors
Follow
Louou : Biotech companies are using capital markets to accelerate global innovation and cooperation
Peng Lim Yap : The prices for a session is 500usd at present,so if is free or discount in states,lucky for you but in Europe countries,how much doses the supply needs?please take out calculator to count.
Peng Lim Yap : Oops is not free.us government had ordered 52.9b usd .Imagine if the population of Europe is 7x or more .That will be at least 53b. X 8or 10
.Space rocket high soon ,once I know the Pfizer is more effective than mck,I switch all my portfolios of mck to Pfizer.